Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
New CRISPR System Makes Cancer Cells Self-Destruct While Sparing Healthy TissueLongevity & Aging

New CRISPR System Makes Cancer Cells Self-Destruct While Sparing Healthy Tissue

Scientists have developed a new CRISPR-based tool called Cas12a2 that can identify and destroy cancer cells without harming healthy ones. Unlike the well-known Cas9 system that edits DNA, Cas12a2 acts like a molecular alarm — once it detects a cancer-specific RNA signal, it shreds the cell's DNA entirely, killing it. In mouse studies, a single treatment reduced tumor volume by approximately 50%. The system worked with remarkable precision, targeting cells with a cancer-driving KRAS mutation while leaving normal cells completely unaffected. Researchers see this as part of a broader shift in medicine toward selective cellular elimination — removing damaged or dangerous cells rather than trying to repair them — with potential implications beyond cancer for aging and age-related disease.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.